Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zai Lab Ltd ADR (ZLAB)

Zai Lab Ltd ADR (ZLAB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,273,412
  • Shares Outstanding, K 95,409
  • Annual Sales, $ 48,960 K
  • Annual Income, $ -268,910 K
  • 60-Month Beta 1.11
  • Price/Sales 246.31
  • Price/Cash Flow N/A
  • Price/Book 8.26
Trade ZLAB with:

Options Overview

Details
  • Implied Volatility 77.46%
  • Historical Volatility 57.66%
  • IV Percentile 96%
  • IV Rank 80.77%
  • IV High 85.72% on 08/19/21
  • IV Low 42.77% on 06/25/21
  • Put/Call Vol Ratio 18.50
  • Today's Volume 39
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 25.00
  • Today's Open Interest 26
  • Open Int (30-Day) 182

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -1.24
  • Number of Estimates 3
  • High Estimate -0.82
  • Low Estimate -1.74
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.18 +5.29%
on 09/17/21
152.82 -15.82%
on 09/07/21
-11.65 (-8.30%)
since 08/17/21
3-Month
110.29 +16.64%
on 07/27/21
178.91 -28.10%
on 07/01/21
-32.45 (-20.14%)
since 06/17/21
52-Week
72.76 +76.80%
on 09/21/20
193.54 -33.53%
on 01/20/21
+47.81 (+59.15%)
since 09/17/20

Most Recent Stories

More News
2 Healthcare Stocks Wall Street Predicts Will Rally by 50% or More

The COVID-19 pandemic has accelerated the pace of the global healthcare market’s growth. With the widespread adoption of digital technologies and increased healthcare spending, the industry is expected...

VTRS : 13.57 (-0.88%)
ZLAB : 128.64 (+1.78%)
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market

/PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and...

ZLAB : 128.64 (+1.78%)
ZCMD : 1.6200 (+3.18%)
Schrodinger and Zai Lab Announce a Global R&D Collaboration in Oncology

Schrodinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688), an innovative...

ZLAB : 128.64 (+1.78%)
SDGR : 62.42 (+2.08%)
Thinking about trading options or stock in Apple, UnitedHealth Group, Zai Lab, PepsiCo, or Pfizer?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, UNH, ZLAB, PEP, and PFE.

AAPL : 146.06 (-1.83%)
PEP : 154.13 (-0.92%)
ZLAB : 128.64 (+1.78%)
PFE : 43.89 (-1.30%)
UNH : 420.16 (+0.80%)
Thinking about trading options or stock in Zai Lab, Novavax, Johnson & Johnson, Marathon Digital, or Riot Blockchain?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZLAB, NVAX, JNJ, MARA, and RIOT.

NVAX : 237.54 (+0.11%)
ZLAB : 128.64 (+1.78%)
MARA : 35.84 (-1.38%)
RIOT : 29.30 (-0.24%)
JNJ : 164.75 (-0.28%)
3 Chinese Stocks Outperforming NIO in 2021

Even though NIO (NIO) has delivered spectacular returns over the past year, Tencent (TME), Bilibili (BILI), and Zai Lab (ZLAB) have outperformed the stock so far this year. Based on growing market demand...

TME : 7.87 (-0.38%)
BILI : 74.44 (+2.37%)
ZLAB : 128.64 (+1.78%)
3 Lesser-Known Biotech Stocks that are Surging

The biotechnology sector has been the focus of investors since the outbreak of the COVID-19 pandemic. Initially, all eyes were on accurate COVID-19 testing, followed by an anxious wait for vaccines. The...

BGNE : 403.14 (+4.65%)
ALNY : 190.34 (+0.07%)
ZLAB : 128.64 (+1.78%)
Why Chinese Stock Bilibili is up More than 300% in 2020

Bilibili Inc.’s (BILI) entertainment platform enables its users to consume and create content. The company has quickly become quite popular as its user base has increased exponentially due to the coronavirus....

BILL : 294.20 (-0.80%)
BIDU : 162.21 (+1.66%)
VIPS : 12.86 (+0.31%)
ZLAB : 128.64 (+1.78%)
Qiming's Portfolio Company Antengene Lists on Main Board of HKEX

, /PRNewswire/ -- Qiming's portfolio company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. The issue price is per share; the stock opens...

BILI : 74.44 (+2.37%)
ZLAB : 128.64 (+1.78%)
SDGR : 62.42 (+2.08%)
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million

, /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), announced today that it had closed a Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital,...

ZLAB : 128.64 (+1.78%)
IMAB : 75.85 (+11.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China....

See More

Key Turning Points

3rd Resistance Point 139.67
2nd Resistance Point 134.88
1st Resistance Point 131.76
Last Price 128.64
1st Support Level 123.85
2nd Support Level 119.06
3rd Support Level 115.94

See More

52-Week High 193.54
Fibonacci 61.8% 147.40
Fibonacci 50% 133.15
Last Price 128.64
Fibonacci 38.2% 118.90
52-Week Low 72.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar